Hidradenitis suppurativa and adalimumab in the COVID-19 era.

Authors :: Marzano AV
Moltrasio C
Genovese G
Muratori S
Dapavo P
Fabbrocini G
Patrizi A
Sechi A
Micali G
Pellegrino M
Gisondi P
Dini V
Bianchi L
Fania L
Offidani A
Prignano F
Atzori L
Miraglia E
Cannavò SP
Bettoli V
Stingeni L
Balestri R
Venturini M
Peris K
Source :: European journal of dermatology : EJD [Eur J Dermatol] 2020 Dec 01; Vol. 30 (6), pp. 748-749.
Publication Year :: 2020

Subjects :: Adult
Aged
Female
Humans
Risk Assessment
Adalimumab therapeutic use
COVID-19 complications
COVID-19 epidemiology
Hidradenitis Suppurativa complications
Hidradenitis Suppurativa drug therapy

Full Text Access

Tools